Insider Stock Trading History of Bacha Jeffrey


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Bacha Jeffrey since year 2005. The trader's CIK number is 1432149. At the time of this reporting, Bacha Jeffrey is the CEO of Delmar Pharmaceuticals, Inc. . (stock ticker symbol DMPI). See this page for all insider trading activities at Delmar Pharmaceuticals, Inc. .


Stock purchases, sales, and option exercises reported by insider Bacha Jeffrey since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-10-06 DMPI Delmar Pharmaceuticals, Inc. Buy 10,000 .88 8,750
2017-06-26 DMPI Delmar Pharmaceuticals, Inc. Buy 6,700 3.60 24,120
2017-06-06 DMPI Delmar Pharmaceuticals, Inc. Buy 5,000 2.12 10,600
2017-05-05 DMPI Delmar Pharmaceuticals, Inc. Buy 2,500 2.20 5,500
2017-02-01 DMPI Delmar Pharmaceuticals, Inc. Buy 4,000 5.00 20,000
2015-11-25 DMPI Delmar Pharmaceuticals, Inc. Buy 7,500 1.47 11,025
2015-10-08 DMPI Delmar Pharmaceuticals, Inc. Buy 3,000 .79 2,370
2015-09-18 DMPI Delmar Pharmaceuticals, Inc. Buy 4,000 .83 3,320
2015-07-25 DMPI Delmar Pharmaceuticals, Inc. Buy 10,000 .60 6,000
2015-07-16 DMPI Delmar Pharmaceuticals, Inc. Buy 50,000 .60 30,000
2015-01-22 DMPI Delmar Pharmaceuticals, Inc. Buy 7,500 .66 4,912
2014-12-09 DMPI Delmar Pharmaceuticals, Inc. Buy 2,500 .90 2,250
2014-11-26 DMPI Delmar Pharmaceuticals, Inc. Buy 2,500 .92 2,300
2014-09-18 DMPI Delmar Pharmaceuticals, Inc. Buy 4,000 .98 3,920
2014-09-15 DMPI Delmar Pharmaceuticals, Inc. Buy 4,985 .75 3,738
2014-03-18 DMPI Delmar Pharmaceuticals, Inc. Buy 10,000 1.30 13,000
2014-02-21 DMPI Delmar Pharmaceuticals, Inc. Buy 5,000 1.00 5,000
2014-02-13 DMPI Delmar Pharmaceuticals, Inc. Buy 5,000 .80 4,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bacha Jeffrey (CEO of Delmar Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.